News

Service to the Citizen Award

VA Innovation Ecosystem leader recognized for the Initiative to End Diabetic Limb Loss.  SOMERVILLE, Mass., June 29, 2021 —  Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, congratulates Suzanne Shirley today on winning the Service to Citizen Award in recognition for her leadership and dedication to the Veteran population […]

Service to the Citizen Award Read More »

Podimetrics & Independence Blue Cross- Virtual Care Management

PHILADELPHIA and SOMERVILLE, Mass., October 26, 2021 — Independence Blue Cross (Independence) and Podimetrics, a virtual care management company dedicated to preventing diabetic amputations, today announced an agreement for Podimetrics to remotely monitor Independence fully insured commercial members who have diabetes and a history of a diabetic foot ulcer with the use of the cellular-connected

Podimetrics & Independence Blue Cross- Virtual Care Management Read More »

Diabetic Foot Ulcer Episode Research -Podimetrics

All-cause mortality is 50% more likely during this common diabetes complication SOMERVILLE, Mass., January 18, 2022 —  Podimetrics, a virtual care support company dedicated to preventing costly and deadly diabetic amputations, today announced results from its latest research, which compared the health of individuals during and after periods of diabetic foot ulceration — open sores

Diabetic Foot Ulcer Episode Research -Podimetrics Read More »

Podimetrics Series C – $45M to help prevent diabetic amputations

Every 4 minutes in the U.S., a patient loses a limb due to diabetes complications  Black Americans face diabetes-related amputations 2x as often as white Americans Podimetrics strives to reduce disparities in diabetes care and unnecessary limb loss SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services

Podimetrics Series C – $45M to help prevent diabetic amputations Read More »

Podimetrics Inc – Strategic Executive Hires for Growth

Longtime Congresswoman and former President and CEO of the Better Medicare Alliance, Allyson Schwartz, also joins Podimetrics’ Advisory Board SOMERVILLE, Mass., May 12, 2022 — Podimetrics Inc, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced four new leadership

Podimetrics Inc – Strategic Executive Hires for Growth Read More »

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022–Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric solutions, presented two newly published clinical studies for the treatment of lymphedema and venous disease with its Dayspring® active compression system that showed significant improvements in patient outcomes. Stanley Rockson,

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments at the AVLS 2022 Annual Congress Read More »

Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients

By Using Mind.Px, Patients Achieve PASI75 Faster than Treatment-as-Usual Cohort SAN DIEGO, CA – October 20, 2022 – Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at the Fall Clinical Dermatology Conference 2022 in Las Vegas, one of the largest US-based dermatology educational

Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients Read More »

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles Company Also Announces Update for Its Lead, Phase 2b Product Candidate Topical Neuromodulator ET-01 Oct 17, 2022 – Woburn, MA Eirion Therapeutics Inc. announced today that the first participants have been dosed in a

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Read More »

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System

OAKLAND, Calif., Oct. 4, 2022 —Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced two clinical data publications for the treatment of lymphedema and venous disease with its Dayspring® active compression system, including results from the multi-center, randomized, crossover head-to-head

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System Read More »

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine

San Carlos, Calif. (October 6, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, will highlight its LimiFlex™ Dynamic Sagittal Tether™ (DST) at the North American Spine Society (NASS)

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine Read More »